View More View Less
  • 1 Semmelweis Egyetem, Általános Orvostudományi Kar II. Belgyógyászati Klinika Budapest Szentkirályi u. 46. 1088
  • 2 Magyar Tudományos Akadémia–Semmelweis Egyetem Molekuláris Medicina Kutatócsoport Budapest
Open access

A probiotikumok a szervezet számára előnyös tulajdonságú, élő mikroorganizmust tartalmazó készítmények. A tápcsatorna baktériumflórájának megváltoztatása kedvező hatású lehet számos emésztőszervi betegség kezelésében. Bár a probiotikumok pontos hatása nem egyértelmű, alkalmazásuk széles körben elterjedt a világ számos országában. Az egyes probiotikumokkal, illetve kombinációkkal kapcsolatos eredmények nem általánosíthatók. Nem tisztázott a kezelés ajánlott dózisa sem. Bár a probiotikumokat általában biztonságos szereknek tekintik, óvatosság indokolt a készítmények rutinszerű alkalmazásával kapcsolatban, mivel a kezelés mellékhatásaként súlyos szövődmények jelenhetnek meg. Összefoglalónkban az emésztőszervi betegségekben alkalmazott probiotikumokkal szerzett tapasztalatokat ismertetjük.

If the inline PDF is not rendering correctly, you can download the PDF file here.

  • Zoetendal, E. G., Akkermans, A. D., Akkermans-van Vliet, W. M. és mtsai: The host genotype affects the bacterial community in the human gastrointestinal tract. Microb. Ecol. Health. Dis., 2001, 13 , 129–134.

    Akkermans-van Vliet W. M. , 'The host genotype affects the bacterial community in the human gastrointestinal tract ' (2001 ) 13 Microb. Ecol. Health. Dis. : 129 -134.

    • Search Google Scholar
  • Gibson, P. R., Moeller, I., Kagelari, O. és mtsai: Contrasting effects of butyrate on the expression of phenotypic markers of differentiation in neoplastic and non-neoplastic colonic epithelial cells in vitro. J. Gastroenterol. Hepatol., 1992, 7 , 165–172.

    Kagelari O. , 'Contrasting effects of butyrate on the expression of phenotypic markers of differentiation in neoplastic and non-neoplastic colonic epithelial cells in vitro ' (1992 ) 7 J. Gastroenterol. Hepatol. : 165 -172.

    • Search Google Scholar
  • Lievin, V., Peiffer, I., Hudault, S. és msai: Bifidobacterium strains from resident infant human gastrointestinal microflora exert antimicrobial activity. Gut, 2000, 47 , 646–652.

    Hudault S. , 'Bifidobacterium strains from resident infant human gastrointestinal microflora exert antimicrobial activity ' (2000 ) 47 Gut : 646 -652.

    • Search Google Scholar
  • Boirivant, M., Strober, W.: The mechanism of action of probiotics. Curr. Opin. Gastroenterol., 2007, 23 , 679–692.

    Strober W. , 'The mechanism of action of probiotics ' (2007 ) 23 Curr. Opin. Gastroenterol. : 679 -692.

    • Search Google Scholar
  • Gibson, G. R., Probert, H. M., Van Loo, J. és mtsai: Dietary modulation of the human colonic microbiota: updating the concept of prebiotics. Nutr. Res. Rev., 2004, 17 , 259–275.

    Loo J. , 'Dietary modulation of the human colonic microbiota: updating the concept of prebiotics ' (2004 ) 17 Nutr. Res. Rev. : 259 -275.

    • Search Google Scholar
  • Cummings, J., Kong, S. C.: Probiotics, prebiotics and antibiotics in inflammatory bowel disease. In Inflammatory bowel disease. Szerk.: Chadwick, D., Goode, J. John Wiley & Sons, Chichester, 2004, 99–114.

    Kong S. C. , '', in Inflammatory bowel disease , (2004 ) -.

  • Hawrelak, J. A., Whitten, D. L., Myers, S. P.: Is Lactoacillus rhamnosus GG effective in preventing the onset of antibiotic-associated diarrhea: a systematic review. Digestion, 2005, 72 , 51–56.

    Myers S. P. , 'Is Lactoacillus rhamnosus GG effective in preventing the onset of antibiotic-associated diarrhea: a systematic review ' (2005 ) 72 Digestion : 51 -56.

    • Search Google Scholar
  • Hickson, M., D’Souza, A. L., Muthu, N. és mtsai: Use of probiotic Lactobacillus preparation to prevent diarrhoea associated with antibiotics: randomized double blind placebo controlled trial. BMJ, 2007, 35 , 80.

    Muthu N. , 'Use of probiotic Lactobacillus preparation to prevent diarrhoea associated with antibiotics: randomized double blind placebo controlled trial ' (2007 ) 35 BMJ : 80 -.

    • Search Google Scholar
  • D’Souza, A. L., Rajkumar, C., Cooke, J. és mtsa: Probiotics in prevention os antibiotic associated diarrhoea: meta-analysis. BMJ, 2002, 324 , 1361.

    Cooke J. , 'Probiotics in prevention os antibiotic associated diarrhoea: meta-analysis ' (2002 ) 324 BMJ : 1361 -.

    • Search Google Scholar
  • Szajewska, H., Mrukowicz, J.: Meta-analysis: non-pathogenic yeast Saccharomyces boulardii in the prevention of antibiotic-associated diarrhea. Aliment. Pharmacol. Ther., 2005, 22 , 365–372.

    Mrukowicz J. , 'Meta-analysis: non-pathogenic yeast Saccharomyces boulardii in the prevention of antibiotic-associated diarrhea ' (2005 ) 22 Aliment. Pharmacol. Ther. : 365 -372.

    • Search Google Scholar
  • Surawicz, C. M., McFarland, L. V., Greenberg, R. N. és mtsai: The search for a better treatment for recurrent Clostridium difficile disease: use of high-dose vancomycin combined with Saccharomyces boulardii. Clin. Infect. Dis., 2000, 31 , 1012–1017.

    Greenberg R. N. , 'The search for a better treatment for recurrent Clostridium difficile disease: use of high-dose vancomycin combined with Saccharomyces boulardii ' (2000 ) 31 Clin. Infect. Dis. : 1012 -1017.

    • Search Google Scholar
  • Plummer, S., Weaver, M. A., Harris, J.C. és mtsai: Clostridium difficile pilot study: effects of probiotic supplementation on the incidence of C. difficile diarrhoea. Int. Microbiol., 2004, 7 , 59–62.

    Harris J.C. , 'Clostridium difficile pilot study: effects of probiotic supplementation on the incidence of C. difficile diarrhoea ' (2004 ) 7 Int. Microbiol. : 59 -62.

    • Search Google Scholar
  • Macfarland, L. V.: Meta-analysis of probiotics for the prevention of antibiotic associated diarrhea and the treatment of Clostridium difficile disease. Am. J. Gastroenterol., 2006, 101 , 812–822.

    Macfarland L. V. , 'Meta-analysis of probiotics for the prevention of antibiotic associated diarrhea and the treatment of Clostridium difficile disease ' (2006 ) 101 Am. J. Gastroenterol. : 812 -822.

    • Search Google Scholar
  • Lawrence, S. J., Korzenik, J. R., Mundy, L. M.: Probiotics for recurrent Clostridium difficile disease. J. Med. Microbiol., 2005, 54 , 905–906.

    Mundy L. M. , 'Probiotics for recurrent Clostridium difficile disease ' (2005 ) 54 J. Med. Microbiol. : 905 -906.

    • Search Google Scholar
  • Lewis, S., Burmeister, S., Cohen, S. és mtsai: Failure of dietary oligofructose to prevent antibiotic-associated diarrhoea. Aliment. Pharmacol. Ther., 2005, 21 , 469–477.

    Cohen S. , 'Failure of dietary oligofructose to prevent antibiotic-associated diarrhoea ' (2005 ) 21 Aliment. Pharmacol. Ther. : 469 -477.

    • Search Google Scholar
  • Lewis, S., Burmeister, S., Brazier, J.: Effect of the probiotic oligofructose on relapse of Clostridium difficile-associated diarrhea: a randomized, controlled study. Clin. Gastroenterol. Hepatol., 2005, 3 , 442–448.

    Brazier J. , 'Effect of the probiotic oligofructose on relapse of Clostridium difficile-associated diarrhea: a randomized, controlled study ' (2005 ) 3 Clin. Gastroenterol. Hepatol. : 442 -448.

    • Search Google Scholar
  • Jonkers, D., Stockbrügger, R.: Review article: probiotics in gastrointestinal and liver diseases. Aliment. Pharmacol. Ther., 2007, 26 , 133–148.

    Stockbrügger R. , 'Review article: probiotics in gastrointestinal and liver diseases ' (2007 ) 26 Aliment. Pharmacol. Ther. : 133 -148.

    • Search Google Scholar
  • Macfarland, L. V.: Meta-analysis of probiotics for the prevention of travelers’s diarrhea. Travel. Med. Infect. Dis., 2007, 5 , 97–103.

    Macfarland L. V. , 'Meta-analysis of probiotics for the prevention of travelers’s diarrhea ' (2007 ) 5 Travel. Med. Infect. Dis. : 97 -103.

    • Search Google Scholar
  • Cummings, J. H., Christie, S., Cole, T. J.: A study of fructo oligosaccharides in the prevention of traveller’s diarrhea. Aliment. Pharmacol. Ther., 2001, 15 , 1139–1145.

    Cole T. J. , 'A study of fructo oligosaccharides in the prevention of traveller’s diarrhea ' (2001 ) 15 Aliment. Pharmacol. Ther. : 1139 -1145.

    • Search Google Scholar
  • Malinen, E., Rinttila, T., Kajander, K. és mtsai: Analysis of the fecal microbiota of irritable bowel syndrome patients and healthy controls with real-time PCR. Am. J. Gastroenterol., 2005, 100 , 373–382.

    Kajander K. , 'Analysis of the fecal microbiota of irritable bowel syndrome patients and healthy controls with real-time PCR ' (2005 ) 100 Am. J. Gastroenterol. : 373 -382.

    • Search Google Scholar
  • Spiller, R.: Review article: probiotics and prebiotics in irritable bowel syndrome. Aliment. Pharmacol. Ther., 2008, 28 , 385–396.

    Spiller R. , 'Review article: probiotics and prebiotics in irritable bowel syndrome ' (2008 ) 28 Aliment. Pharmacol. Ther. : 385 -396.

    • Search Google Scholar
  • Quigley, E. M.: The efficacy of probiotics in IBS. J. Clin. Gastroenterol., 2008, 42 , 85–90.

    Quigley E. M. , 'The efficacy of probiotics in IBS ' (2008 ) 42 J. Clin. Gastroenterol. : 85 -90.

    • Search Google Scholar
  • Nobaek, S., Johanson, M. L., Molin, G. és mtsai: Alteration of intestinal microflora is associated with reduction in abdominal bloating and pain in patients with irritable bowel syndrome. Am. J. Gastroenterol., 2000, 95 , 1231–1238.

    Molin G. , 'Alteration of intestinal microflora is associated with reduction in abdominal bloating and pain in patients with irritable bowel syndrome ' (2000 ) 95 Am. J. Gastroenterol. : 1231 -1238.

    • Search Google Scholar
  • Kim, H. J., Camilleri, M., McKinzie, S. és mtsai: A randomized controlled trial of a probiotic, VSL#3 on gut transit and symptoms in diarrhoea-predominant IBS. Aliment. Pharmacol. Ther., 2003, 17 , 895–904.

    McKinzie S. , 'A randomized controlled trial of a probiotic, VSL#3 on gut transit and symptoms in diarrhoea-predominant IBS ' (2003 ) 17 Aliment. Pharmacol. Ther. : 895 -904.

    • Search Google Scholar
  • Saggioro, A.: Probiotics in the treatment of irritable bowel syndroma. J. Clin. Gastroenterol., 2004, 38 , 104–106.

    Saggioro A. , 'Probiotics in the treatment of irritable bowel syndroma ' (2004 ) 38 J. Clin. Gastroenterol. : 104 -106.

    • Search Google Scholar
  • O’Mahony, L., McCarthy, J., Kelly, P. és mtsai: Lactobacillus and Bifidobacterium in irritable bowel syndrome (IBS): symptom responses and relationship to cytokine profiles. Gastroenterology, 2005, 128 , 541–551.

    Kelly P. , 'Lactobacillus and Bifidobacterium in irritable bowel syndrome (IBS): symptom responses and relationship to cytokine profiles ' (2005 ) 128 Gastroenterology : 541 -551.

    • Search Google Scholar
  • Stone-Dorshow, T., Levitt, M. D.: Gaseous response to ingestion of a poorly absorbed fructo-oligosaccharide sweetener. Am. J. Clin. Nutr., 1987, 46 , 61–65.

    Levitt M. D. , 'Gaseous response to ingestion of a poorly absorbed fructo-oligosaccharide sweetener ' (1987 ) 46 Am. J. Clin. Nutr. : 61 -65.

    • Search Google Scholar
  • Hunter, J. O., Tuffnel, Q., Lee, A. J.: Controlled trial of oligofructose in the management of irritable bowel syndrome. J. Nutr., 1999, 127 , 1451–1453.

    Lee A. J. , 'Controlled trial of oligofructose in the management of irritable bowel syndrome ' (1999 ) 127 J. Nutr. : 1451 -1453.

    • Search Google Scholar
  • Bhan, A. K., Mizoguchi, E., Smith, R. N. és mtsa: Colitis in transgenic and knockout animals as models of human inflammatorx bowel disease. Immunol. Rev., 1999, 169 , 195–207.

    Smith R. N. , 'Colitis in transgenic and knockout animals as models of human inflammatorx bowel disease ' (1999 ) 169 Immunol. Rev. : 195 -207.

    • Search Google Scholar
  • Neut, C., Bulois, P., Desreumaux, P. és mtsai: Changes in the bacterial flora of the neoterminal ileum after ileocolonic resection for Crohn’s disease. Am. J. Gastroenterol., 2002, 97 , 939–946.

    Desreumaux P. , 'Changes in the bacterial flora of the neoterminal ileum after ileocolonic resection for Crohn’s disease ' (2002 ) 97 Am. J. Gastroenterol. : 939 -946.

    • Search Google Scholar
  • Swidsinski, A., Ladhoff, A., Pernthaler, A. és mtsai: Mucosal flora in inflammatory bowel disease. Gastroenterology, 2002, 122 , 44–54.

    Pernthaler A. , 'Mucosal flora in inflammatory bowel disease ' (2002 ) 122 Gastroenterology : 44 -54.

    • Search Google Scholar
  • Fujimori, S., Tatsuguchi, A., Gudis, K. és mtsai: High dose probiotic and prebiotic cotherapy for remission induction of active Crohn’s disease. J. Gastroenterol. Hepatol., 2007, 22 , 1199–1204.

    Gudis K. , 'High dose probiotic and prebiotic cotherapy for remission induction of active Crohn’s disease ' (2007 ) 22 J. Gastroenterol. Hepatol. : 1199 -1204.

    • Search Google Scholar
  • Malchow, H. A.: Crohn’s disease and Escherichia coli. A new approach in therapy to maintain remission of colonic Crohn’s disease? J. Clin. Gastroenterol., 1997, 25 , 653–658.

    Malchow H. A. , 'Crohn’s disease and Escherichia coli. A new approach in therapy to maintain remission of colonic Crohn’s disease? ' (1997 ) 25 J. Clin. Gastroenterol. : 653 -658.

    • Search Google Scholar
  • Bousvaros, A., Guandalini, S., Baldassano, R. és mtsai: A randomized, doubleblind trial of Lactobacillus GG versus placebo in addition to standard maintenance therapy for children with Crohn’s disease. Inflamm. Bowel. Dis., 2005, 11 , 833–839.

    Baldassano R. , 'A randomized, doubleblind trial of Lactobacillus GG versus placebo in addition to standard maintenance therapy for children with Crohn’s disease ' (2005 ) 11 Inflamm. Bowel. Dis. : 833 -839.

    • Search Google Scholar
  • Guslandi, M., Mezzi, G., Sorghi, M. és mtsa: Saccharomyces boulardii in maintenance treatment of Crohn’s disease. Dig. Dis. Sci., 2000, 45 , 1462–1464.

    Sorghi M. , 'Saccharomyces boulardii in maintenance treatment of Crohn’s disease ' (2000 ) 45 Dig. Dis. Sci. : 1462 -1464.

    • Search Google Scholar
  • Prantera, C., Scribano, M. L., Falasco, G. és mtsai: Ineffectiveness of probiotics in preventing recurrence after curative resection for Crohn’s disease: a randomised controlled trial with Lactobacillus GG. Gut, 2002, 51 , 405–409.

    Falasco G. , 'Ineffectiveness of probiotics in preventing recurrence after curative resection for Crohn’s disease: a randomised controlled trial with Lactobacillus GG ' (2002 ) 51 Gut : 405 -409.

    • Search Google Scholar
  • Marteau, P., Lemann, M., Seksik, P. és mtsai: Ineffectiveness of Lactobacillus johnsonii LA1 for prophylaxis of postoperative recurrence in Crohn’s disease: a randomised, double blind, placebo controlled GETAID trial. Gut, 2006, 55 , 842–847.

    Seksik P. , 'Ineffectiveness of Lactobacillus johnsonii LA1 for prophylaxis of postoperative recurrence in Crohn’s disease: a randomised, double blind, placebo controlled GETAID trial ' (2006 ) 55 Gut : 842 -847.

    • Search Google Scholar
  • Chermesh, I., Tamir, A., Reshef, R. és mtsai: Failure of synbiotic 2000 to prevent postoperative recurrence of Crohn’s disease. Dig. Dis. Sci., 2007, 52 , 385–389.

    Reshef R. , 'Failure of synbiotic 2000 to prevent postoperative recurrence of Crohn’s disease ' (2007 ) 52 Dig. Dis. Sci. : 385 -389.

    • Search Google Scholar
  • Furrie, E., Macfarlane, S., Kennedy, A. és mtsai: Synbiotic therapy (Bifidobacterium longum/Synergy 1) initiates resolution of inflammation in patients with active ulcerative colitis: a randomised controlled pilot trial. Gut, 2005, 54 , 242–249.

    Kennedy A. , 'Synbiotic therapy (Bifidobacterium longum/Synergy 1) initiates resolution of inflammation in patients with active ulcerative colitis: a randomised controlled pilot trial ' (2005 ) 54 Gut : 242 -249.

    • Search Google Scholar
  • Tursi, A., Brandimarte, G., Giorgetti, G. és mtsai: Low-dose balsalazide plus a high-potency probiotic preparation is more effective than balsalazide alone or mesalazine in the treatment of acute mild-to-moderate ulcerative colitis. Med. Sci. Monit., 2004, 10 , 126–131.

    Giorgetti G. , 'Low-dose balsalazide plus a high-potency probiotic preparation is more effective than balsalazide alone or mesalazine in the treatment of acute mild-to-moderate ulcerative colitis ' (2004 ) 10 Med. Sci. Monit. : 126 -131.

    • Search Google Scholar
  • Kruis, W., Schütz, E., Fric, P. és mtsai: Double-blind comparison of an oral Escherichia coli preparation and mesalazine in maintaining remission of ulcerative colitis. Aliment. Pharmacol. Ther., 1997, 11 , 853–858.

    Fric P. , 'Double-blind comparison of an oral Escherichia coli preparation and mesalazine in maintaining remission of ulcerative colitis ' (1997 ) 11 Aliment. Pharmacol. Ther. : 853 -858.

    • Search Google Scholar
  • Kruis, W., Fric, P., Pokrotnieks, J. és mtsai: Maintaining remission of ulcerative colitis with the probiotic Escherichia coli Nissle 1917 is as effective as with standard mesalazine. Gut, 2004, 53 , 1617–1623.

    Pokrotnieks J. , 'Maintaining remission of ulcerative colitis with the probiotic Escherichia coli Nissle 1917 is as effective as with standard mesalazine ' (2004 ) 53 Gut : 1617 -1623.

    • Search Google Scholar
  • Rembacken, B., Smelling, A., Hawkey, P. M. és mtsai: Non-pathogenic Escherichia coli versus mesalazine for the treatment of ulcerative colitis: a randomised trial. Lancet, 1999, 354 , 635–639.

    Hawkey P. M. , 'Non-pathogenic Escherichia coli versus mesalazine for the treatment of ulcerative colitis: a randomised trial ' (1999 ) 354 Lancet : 635 -639.

    • Search Google Scholar
  • Zocco, M., dal Verme, L., Cremonini, F. és mtsai: Efficacy of Lactobacillus GG in maintaining remission of ulcerative colitis. Aliment. Pharmacol. Ther., 2006, 23 , 1567–1574.

    Cremonini F. , 'Efficacy of Lactobacillus GG in maintaining remission of ulcerative colitis ' (2006 ) 23 Aliment. Pharmacol. Ther. : 1567 -1574.

    • Search Google Scholar
  • Simchuk, E., Thirlby, R.: Risk factors and true incidence of pouchitis in patients after ileal pouch-anal anastomosis. World J. Surg., 2000, 24 , 851–856.

    Thirlby R. , 'Risk factors and true incidence of pouchitis in patients after ileal pouch-anal anastomosis ' (2000 ) 24 World J. Surg. : 851 -856.

    • Search Google Scholar
  • Kuisma, J., Mentula, S., Jarvinen, H. és mtsai: Effect of Lactobacillus rhamnosus GG on ileal pouch inflammation and microbial flora. Aliment. Pharmacol. Ther., 2003, 17 , 509–515.

    Jarvinen H. , 'Effect of Lactobacillus rhamnosus GG on ileal pouch inflammation and microbial flora ' (2003 ) 17 Aliment. Pharmacol. Ther. : 509 -515.

    • Search Google Scholar
  • Welters, C. F., Heineman, E., Thunnissen, F. B. és mtsai: Effect of dietary insulin supplementation on inflammation of pouch mucosa in patients with an ileal pouch-anal anastomosis. Dis. Colon. Rectum., 2002, 45 , 621–627.

    Thunnissen F. B. , 'Effect of dietary insulin supplementation on inflammation of pouch mucosa in patients with an ileal pouch-anal anastomosis ' (2002 ) 45 Dis. Colon. Rectum. : 621 -627.

    • Search Google Scholar
  • Gionchetti, P., Rizzello, F., Venturi, A. és mtsai: Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: a doubleblind, placebo-controlled trial. Gastroenterology, 2000, 119 , 305–309.

    Venturi A. , 'Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: a doubleblind, placebo-controlled trial ' (2000 ) 119 Gastroenterology : 305 -309.

    • Search Google Scholar
  • Shen, B., Brzezinski, A., Fazio, V. W. és mtsai: Maintenance therapy with a probiotic in antibiotic-dependent pouchitis: experience in clinical practice. Aliment. Pharmacol. Ther., 2005, 22 , 721–728.

    Fazio V. W. , 'Maintenance therapy with a probiotic in antibiotic-dependent pouchitis: experience in clinical practice ' (2005 ) 22 Aliment. Pharmacol. Ther. : 721 -728.

    • Search Google Scholar
  • Gionchetti, P., Rizzello, F., Helwig, U. és mtsai: Prophylaxis of pouchitis onset with probiotic therapy: a double-blind, placebo-controlled trial. Gastroenterology, 2003, 124 , 1202–1209.

    Helwig U. , 'Prophylaxis of pouchitis onset with probiotic therapy: a double-blind, placebo-controlled trial ' (2003 ) 124 Gastroenterology : 1202 -1209.

    • Search Google Scholar
  • Frić, P., Zavoral, M.: The effect of non-pathogenic Escherichia coli in symptomatic uncomplicated diverticular disease of the colon. Eur. J. Gastroenterol. Hepatol., 2003, 15 , 313–315.

    Zavoral M. , 'The effect of non-pathogenic Escherichia coli in symptomatic uncomplicated diverticular disease of the colon ' (2003 ) 15 Eur. J. Gastroenterol. Hepatol. : 313 -315.

    • Search Google Scholar
  • Almeida, J., Galhenage, S., Yu, J. és mtsai: Gut flora and bacterial translocation in chronic liver disease. World J. Gastroenterol., 2006, 12 , 1493–1502.

    Yu J. , 'Gut flora and bacterial translocation in chronic liver disease ' (2006 ) 12 World J. Gastroenterol. : 1493 -1502.

    • Search Google Scholar
  • Wiest, R., Garcia-Tsao, G.: Bacterial translocation (BT) in cirrhosis. Hepatology, 2005, 41 , 422–433.

    Garcia-Tsao G. , 'Bacterial translocation (BT) in cirrhosis ' (2005 ) 41 Hepatology : 422 -433.

    • Search Google Scholar
  • Sheth, A. A., Garcia-Tsao, G.: Probiotics and liver disease. J. Clin. Gastroenterol., 2008, 42 , 80–84.

    Garcia-Tsao G. , 'Probiotics and liver disease ' (2008 ) 42 J. Clin. Gastroenterol. : 80 -84.

  • Loguercio, C., Abbiati, R., Rinaldi, M. és mtsai: Long-term effects of Enterococcus faecium SF68 versus lactulose in the treatment of patients with cirrhosis and grade 1 to 2 hepatic encephalopathy. J. Hepatol., 1995, 23 , 39–46.

    Rinaldi M. , 'Long-term effects of Enterococcus faecium SF68 versus lactulose in the treatment of patients with cirrhosis and grade 1 to 2 hepatic encephalopathy ' (1995 ) 23 J. Hepatol. : 39 -46.

    • Search Google Scholar
  • Liu, Q., Duan, Z. P., Ha, D. K. és mtsai: Symbiotic modulation of gut flora: effect on minimal hepatic encephalopathy in patients with cirrhosis. Hepatology, 2004, 39 , 1441–1449.

    Ha D. K. , 'Symbiotic modulation of gut flora: effect on minimal hepatic encephalopathy in patients with cirrhosis ' (2004 ) 39 Hepatology : 1441 -1449.

    • Search Google Scholar
  • Malaguarnera, M., Greco, F., Barone, G. és mtsai: Bifidobacterium longum with fructo-oligosaccharide (FOS) treatment in minimal hepatic encephalopathy: a randomized, double-blind, placebo-controlled study. Dig. Dis. Sci., 2007, 52 , 3259–3265.

    Barone G. , 'Bifidobacterium longum with fructo-oligosaccharide (FOS) treatment in minimal hepatic encephalopathy: a randomized, double-blind, placebo-controlled study ' (2007 ) 52 Dig. Dis. Sci. : 3259 -3265.

    • Search Google Scholar
  • Li, Z., Yang, S., Lin, H. és mtsai: Probiotics and antibodies to TNF inhibit inflammatory activity and improve nonalcoholic fatty liver disease. Hepatology, 2003, 37 , 343–350.

    Lin H. , 'Probiotics and antibodies to TNF inhibit inflammatory activity and improve nonalcoholic fatty liver disease ' (2003 ) 37 Hepatology : 343 -350.

    • Search Google Scholar
  • Van Minnen, L. P., Timmerman, H. M., Lutgendorff, F. és mtsai: Modification of intestinal flora with multispecies probiotics reduces bacterial translocation and improves clinical course in a rat model of acute pancreatitis. Surgery, 2007, 141 , 470–478.

    Lutgendorff F. , 'Modification of intestinal flora with multispecies probiotics reduces bacterial translocation and improves clinical course in a rat model of acute pancreatitis ' (2007 ) 141 Surgery : 470 -478.

    • Search Google Scholar
  • Oláh, A., Belágyi, T., Issekutz, A. és mtsai: Randomized clinical trial of specific lactobacillus and fibre supplement to early enteral nutrition in patients with acute pancreatitis. Br. J. Surg., 2002, 89 , 1103–07.

    Issekutz A. , 'Randomized clinical trial of specific lactobacillus and fibre supplement to early enteral nutrition in patients with acute pancreatitis ' (2002 ) 89 Br. J. Surg. : 1103 -07.

    • Search Google Scholar
  • Qin, H. L., Zheng, J. J., Tong, D. N. és mtsai: Effect of lactobacillus plantarum enteral feeding on the gut permeability and septic complications in the patients with acute pancreatitis. Eur. J. Clin. Nutr., 2008, 62 , 923–930.

    Tong D. N. , 'Effect of lactobacillus plantarum enteral feeding on the gut permeability and septic complications in the patients with acute pancreatitis ' (2008 ) 62 Eur. J. Clin. Nutr. : 923 -930.

    • Search Google Scholar
  • Besselink, M. G., van Santvoort, H. C., Buskens, E. és mtsai: Probiotic prophylaxis in predicted severe acute pancreatitis: a randomised, double-blind, placebo-controlled trial. Lancet, 2008, 371 , 651–659.

    Buskens E. , 'Probiotic prophylaxis in predicted severe acute pancreatitis: a randomised, double-blind, placebo-controlled trial ' (2008 ) 371 Lancet : 651 -659.

    • Search Google Scholar
  • Gasser, F.: Safety of lactic-acid bacteria and their occurrence in human clinical infections. Bull. Inst. Pasteur., 1994, 92 , 45–67.

    Gasser F. , 'Safety of lactic-acid bacteria and their occurrence in human clinical infections ' (1994 ) 92 Bull. Inst. Pasteur. : 45 -67.

    • Search Google Scholar
  • Fedorak, R. N.: Probiotics in the management of inflammatory bowel disease? Am. J. Gastroenterology, 2007, 102 , 22–28.

    Fedorak R. N. , 'Probiotics in the management of inflammatory bowel disease? ' (2007 ) 102 Am. J. Gastroenterology : 22 -28.

    • Search Google Scholar